Next-generation malarial vaccines

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A vaccine platform developed from a synthetic polymeric glyco-adjuvant and reversibly conjugated to an antigen was shown to target dendritic cells leading to cellular and humoral immune response against malaria.
Original languageEnglish
Pages (from-to)94-96
JournalNat. Mater.
Volume18
Issue number2
DOIs
Publication statusPublished - 1 Feb 2019

Cite this